Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tristan J Vaughan

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Design|March 12, 2015
Rheumatology: a force for change in monoclonal antibodiesDavid C Lowe, Tristan J Vaughan
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Evolution of biologics screening technologiesPeter Cariuk, Matthew J Gardener, Tristan J Vaughan
Journal of Immunological Methods|December 3, 2014
Isolation of high-affinity, neutralizing anti-idiotype antibodies by phage and ribosome display for application in immunogenicity and pharmacokinetic analysesStacey E Chin, Franco Ferraro, Maria Groves, et al.
Journal of Biomolecular Screening|April 13, 2012
Feasibility of implementing cell-based pathway reporter assays in early high-throughput screening assay cascades for antibody drug discoveryAlison J Smith, Michael K Hancock, Kun Bi, et al.
Plos One|May 20, 2016
Overcoming the Refractory Expression of Secreted Recombinant Proteins in Mammalian Cells through Modification of the Signal Peptide and Adjacent Amino AcidsGülin Güler-Gane, Sara Kidd, Sudharsan Sridharan, et al.
Plos One|March 30, 2019
Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potencyChristina Schindler, Andie Collinson, Carl Matthews, et al.
Journal of Biomolecular Screening|October 10, 2015
Isolation of Potent CGRP Neutralizing Antibodies Using Four Simple AssaysFrances Neal, Joanne Arnold, Christine J Rossant, et al.
Nature Chemistry|May 16, 2024
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potencyAnna M Puszkarska, Bruck Taddese, Jefferson Revell, et al.
Mabs|November 22, 2013
Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversityMaria A T Groves, Lily Amanuel, Jamie I Campbell, et al.
Endocrinology|March 20, 2019
Interactions Between the Gravitostat and the Fibroblast Growth Factor System for the Regulation of Body WeightVilborg Palsdottir, Sara H Windahl, Daniel A Hägg, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|March 12, 2015
Rheumatology: a force for change in monoclonal antibodiesDavid C Lowe, Tristan J Vaughan
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Evolution of biologics screening technologiesPeter Cariuk, Matthew J Gardener, Tristan J Vaughan
Journal of Immunological Methods|December 3, 2014
Isolation of high-affinity, neutralizing anti-idiotype antibodies by phage and ribosome display for application in immunogenicity and pharmacokinetic analysesStacey E Chin, Franco Ferraro, Maria Groves, et al.
Journal of Biomolecular Screening|April 13, 2012
Feasibility of implementing cell-based pathway reporter assays in early high-throughput screening assay cascades for antibody drug discoveryAlison J Smith, Michael K Hancock, Kun Bi, et al.
Plos One|May 20, 2016
Overcoming the Refractory Expression of Secreted Recombinant Proteins in Mammalian Cells through Modification of the Signal Peptide and Adjacent Amino AcidsGülin Güler-Gane, Sara Kidd, Sudharsan Sridharan, et al.
Plos One|March 30, 2019
Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potencyChristina Schindler, Andie Collinson, Carl Matthews, et al.
Journal of Biomolecular Screening|October 10, 2015
Isolation of Potent CGRP Neutralizing Antibodies Using Four Simple AssaysFrances Neal, Joanne Arnold, Christine J Rossant, et al.
Nature Chemistry|May 16, 2024
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potencyAnna M Puszkarska, Bruck Taddese, Jefferson Revell, et al.
Mabs|November 22, 2013
Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversityMaria A T Groves, Lily Amanuel, Jamie I Campbell, et al.
Endocrinology|March 20, 2019
Interactions Between the Gravitostat and the Fibroblast Growth Factor System for the Regulation of Body WeightVilborg Palsdottir, Sara H Windahl, Daniel A Hägg, et al.
Pageof 4